DENVER --(BUSINESS WIRE)--Jan. 9, 2025-- TriSalus Life Sciences ® , Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), TriSalus Life Sciences seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies and our
James Young Appointed Chief Financial Officer, Richard Marshak Appointed Chief Commercial Officer, Jodi Devlin Appointed Chief of Clinical Strategy and Operations DENVER --(BUSINESS WIRE)--Jan. 8, 2025-- TriSalus Life Sciences, Inc. , (Nasdaq: TLSI), an oncology company dedicated to improving